XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance at Jan. 30, 2022 $ 53,295 $ 207,884 $ (51) $ 261,128
Balance (in Shares) at Jan. 30, 2022 11,922,000      
Net income   8,726   8,726
Unrealized gain loss on defined benefit plan, net of tax     32 32
Cash dividends paid   (4,794)   (4,794)
Purchase and retirement of common stock $ (315) (822)   (1,137)
Purchase and retirement of common stock (in Shares) (68,000)      
Restricted stock grants, net of forfeitures $ (102)     (102)
Restricted stock grants, net of forfeitures (in Shares) 105,000      
Restricted stock compensation cost $ 667     667
Performance-based restricted stock units costs 308     308
Balance at Jul. 31, 2022 $ 53,853 210,994 (19) 264,828
Balance (in Shares) at Jul. 31, 2022 11,959,000      
Balance at May. 01, 2022 $ 53,649 208,678 (65) 262,262
Balance (in Shares) at May. 01, 2022 12,002,000      
Net income   5,543   5,543
Unrealized gain loss on defined benefit plan, net of tax     46 46
Cash dividends paid   (2,405)   (2,405)
Purchase and retirement of common stock $ (315) (822)   (1,137)
Purchase and retirement of common stock (in Shares) (68,000)      
Restricted stock grants, net of forfeitures $ (6)     (6)
Restricted stock grants, net of forfeitures (in Shares) 25,000      
Restricted stock compensation cost $ 371     371
Performance-based restricted stock units costs 154     154
Balance at Jul. 31, 2022 $ 53,853 210,994 (19) 264,828
Balance (in Shares) at Jul. 31, 2022 11,959,000      
Balance at Jan. 29, 2023 $ 50,770 184,386 865 $ 236,021
Balance (in Shares) at Jan. 29, 2023 11,197,000     11,197,000
Net income   2,234   $ 2,234
Unrealized gain loss on defined benefit plan, net of tax     (106) (106)
Cash dividends paid   (4,856)   (4,856)
Purchase and retirement of common stock $ (2,252) (6,416)   $ (8,668)
Purchase and retirement of common stock (in Shares) (473,000)     473,463
Restricted stock grants, net of forfeitures $ (150)     $ (150)
Restricted stock grants, net of forfeitures (in Shares) 95,000      
Restricted stock compensation cost $ 807     807
Performance-based restricted stock units costs 386     386
Balance at Jul. 30, 2023 $ 49,561 175,348 759 $ 225,668
Balance (in Shares) at Jul. 30, 2023 10,819,000     10,819,000
Balance at Apr. 30, 2023 $ 50,067 180,152 812 $ 231,031
Balance (in Shares) at Apr. 30, 2023 11,029,000      
Net income   785   785
Unrealized gain loss on defined benefit plan, net of tax     (53) (53)
Cash dividends paid   (2,412)   (2,412)
Purchase and retirement of common stock $ (1,171) (3,177)   (4,348)
Purchase and retirement of common stock (in Shares) (246,000)      
Restricted stock grants, net of forfeitures (in Shares) 36,000      
Restricted stock compensation cost $ 472     472
Performance-based restricted stock units costs 193     193
Balance at Jul. 30, 2023 $ 49,561 $ 175,348 $ 759 $ 225,668
Balance (in Shares) at Jul. 30, 2023 10,819,000     10,819,000